Connective tissue diseases
Conditions
Interventions
CTD patient group:None
Healthy control group:None
Sponsors
Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong Univers
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1: CTD patients are patients who seek treatment at Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology (initial treatment+recurrence) and meet the classification criteria of the American Society of Rheumatology in 1982 2: At the time of enrollment, the patient's age should be = 18 years old 3: Patients who are enrolled need to be aware of the biological samples they have received and voluntarily sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1: Patients diagnosed with tumors within the first 6 months of this study 2: Patients with infectious diseases transmitted through blood sources (such as HIV, HBV, HCV, etc.) 3: Patients in the active phase of acute or chronic infections 4: The patient refused to comply with the requirements of this study to complete the research work 5: Any other circumstances that the researcher deems unsuitable for participation in this experiment (due to other reasons including management reasons).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immune cell subpopulation differentiation;Changes in CD markers on the surface of immune cells; | — |
Countries
China
Contacts
Public ContactJixin Zhong
Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College, Huazhong Univers
Outcome results
None listed